Eli Lilly

Obesity

First GLP-1 weight-loss pill on sale in the US within weeks for $149 a month

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose available in early January for US$149.

Orforglipron looks likely to be the first oral GLP-1 approved for sale

Obesity

First-of-its-kind pill offers 30-lb weight loss – and it's set for 2026 launch

It looks like we'll see oral GLP-1 drugs on the market by 2026, with Eli Lilly reporting impressive results from a large, robust 72-week trial that saw obese patients lose an average of 27.3 lb, or 12.4% of their body weight, with a once-daily pill.

This time next year, you may be swapping GLP-1 injections for oral medication i

Obesity

Breakthrough weight-loss pill expected to launch within 12 months

The first once-daily oral GLP-1 medication could be on shelves by this time next year, making the weight-loss drug easier to take and potentially cheaper. In the race to be the first, Novo Nordisk has scored a huge win, while Pfizer has failed again.